Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The investigators hypothesize that the intake of Omni-Biotic® 10 AAD can reduce the duration of diarrhea in Covid-19 disease. The investigators further hypothesize that Omni-Biotic® 10 AAD can reduce stool frequency, improve stool consistency, improve other gastrointestinal symptoms of Covid-19, reduce disease duration and severity, reduce intestinal inflammation and can improve dysbiosis. The investigators aim to perform a randomized, double blind, placebo-controlled study using telemedicine in patients with Covid-19 disease.
Description: Duration of diarrhea (defined as days with 3 or more loose stools)
Measure: Diarrhea Time: 30 daysDescription: stool evacuations per days
Measure: Stool frequency Time: 30 daysDescription: Stool consistency according to Bristol stool scale for each evacuation, score 1-7, a higher score means a lower stool consistancy
Measure: Stool consistency Time: 30 daysDescription: presence of anorexia, nausea, vomiting, abdominal pain, bloating (yes/no)
Measure: Gastrointestinal symptoms Time: 30 daysDescription: days patients feel sick, are not able to work or are on sick leave
Measure: Duration of Covid-19 disease Time: 30 daysDescription: mild/moderate/severe
Measure: Severity of Covid-19 disease Time: 30 daysDescription: measured by ELISA
Measure: Stool Calprotectin Time: 30 daysDescription: measured by ELISA
Measure: Stool Zonulin Time: 30 daysDescription: 16S RNA sequencing
Measure: Microbiome composition Time: 30 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports